Product launches such as the launch of QuikClot by Z-Medica in January 2018 is expected to boost the market growth. It is a hemostatic device, which stops bleeding significantly faster and is more effective than standard gauzes. Since the adoption of QuikClot combat gauze by the United States Army Institute for Surgical Research (USAISR), the Naval Medical Research Center (NMRC), and the Committee on Tactical Combat Casualty Care (CoTCCC), over six million units of QuikClot combat gauze has been sold in 2018.
Moreover, Quicklott’s usage in the field signifies an innovative step forward in combat dressing and hemostatic device applications.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients